It is noteworthy that Man-HSA(D494N)-IFNα2b exhibited superior therapeutic effects compared to IFNα2b against Con-A-induced hepatitis model mice (Figure 5(C)). The gene discussed is IFNA2; the disease is hepatitis A virus infection.